A groundbreaking study has identified four biologically distinct subtypes of autism, each characterized by unique clusters of symptoms, developmental patterns, and genetic traits.
Published in Nature Genetics, this research deepens our understanding of autism spectrum disorder (ASD) and offers hope for more personalized approaches to diagnosis and treatment.
Autism is widely recognized as a spectrum, with a common saying among those affected: “If you’ve met one person with autism, you’ve met one person with autism.” This reflects the vast diversity in how autism presents, including social communication challenges and repetitive behaviors.
The new study analyzed detailed data from over 5,000 autistic children aged 4 to 18, drawn from the SPARK cohort, which collects genetic and clinical information.
By examining more than 230 traits — such as social interactions, repetitive behaviors, and developmental milestones — researchers applied computational models to group individuals into four distinct autism subtypes:
Social and Behavioral Challenges (37% of participants): Children in this group show social difficulties and repetitive behaviors but typically achieve developmental milestones on schedule. They often experience co-occurring conditions like ADHD, anxiety, or depression.
Mixed ASD with Developmental Delay (19%): This group shows delayed milestones such as walking and talking but fewer psychiatric conditions. They experience social and repetitive behavior challenges.
Moderate Challenges (34%): Individuals display core autism features less intensely, with typical developmental progress and fewer co-occurring psychiatric disorders.
Broadly Affected (10%): These children face more severe developmental delays, communication challenges, repetitive behaviors, and higher rates of psychiatric conditions like mood disorders.
Significantly, the study linked each subtype to distinct genetic and biological pathways, highlighting that autism’s causes are complex and varied. For instance, the Broadly Affected group had the highest number of non-inherited genetic mutations related to autism, while the Mixed ASD with Developmental Delay group showed more inherited rare variants.
Experts say these findings represent a major advance toward precision medicine in autism care, where treatment plans can be tailored based on a person’s unique genetic and clinical profile. This research also challenges oversimplified views about autism causes, emphasizing its multifaceted nature.
While this study focuses on children, future research aims to explore these subtypes in adults and to refine or discover additional subtypes as more data becomes available.
Ultimately, this work supports the view of autism as a complex, multidimensional condition with diverse biological roots, paving the way for more accurate diagnoses and personalized health care strategies for individuals on the spectrum.
